Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | BID | P55957 | 1/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30128417 | 1.00 | FOLH1 (0.51) | FOLH1ALDH1A1BIDBCL2L1MCL1 | |
| SCHEMBL291607 | 0.89 | FOLH1 (0.54) | FOLH1ALDH1A1TSHRKMT2APTK2B | |
| SCHEMBL7201890 | 0.83 | FOLH1 (0.47) | FOLH1ALDH1A1BIDBCL2L1MCL1 | |
| SCHEMBL23043892 | 0.83 | ALDH1A1 (0.47) | FOLH1ALDH1A1MCL1TSHRKMT2A | |
| SCHEMBL3001321 | 0.82 | FOLH1 (0.55) | FOLH1ALDH1A1BIDBCL2L1MCL1 | |
| SCHEMBL3680999 | 0.80 | ALDH1A1 (0.55) | FOLH1ALDH1A1TSHRKMT2ASMN1; SMN2 | |
| SCHEMBL5682890 | 0.80 | KMT2A (0.45) | FOLH1ALDH1A1TSHRKMT2AHTT | |
| SCHEMBL22912 | 0.80 | FOLH1 (0.59) | FOLH1ALDH1A1BIDBCL2L1MCL1 | |
| SCHEMBL9011107 | 0.80 | FOLH1 (0.49) | FOLH1BIDBCL2L1MCL1BAK1 | |
| SCHEMBL18038407 | 0.80 | BID (0.65) | FOLH1BIDBCL2L1MCL1BAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4110772-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | Cullgen (Shanghai), Inc. (CN) | 2023-01-04 | — | — | EP | disclosed |
| EP-3841098-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | Cullgen (Shanghai), Inc. (CN) | 2021-06-30 | — | — | EP | disclosed |
| CN-112888681-A | Tropomyosin Receptor Kinase (TRK) degrading compounds and methods of use | 上海睿跃生物科技有限公司 | 2021-06-01 | — | — | CN | disclosed |
| WO-2020038415-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | CULLGEN (SHANGHAI), INC. (CN) | 2020-02-27 | — | — | WO | disclosed |